UB Paderborn / Katalog / Suche / in CDI

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.966-979

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.949-959

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatocellular carcinoma in Central Europe: prognostic features and survival

Gut, 2001-01, Vol.48 (1), p.103-109

2001

Link zum Volltext

Verfügbarkeit prüfen

Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori

Clinical microbiology and infection, 2018-03, Vol.24 (3), p.267-272

2018

Link zum Volltext

Verfügbarkeit prüfen

Pilot study: rapamycin in advanced hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2010-09, Vol.32 (6), p.763-768

2010

Link zum Volltext

Verfügbarkeit prüfen

Elevated serum levels of sFas in acute viral hepatitis

European journal of gastroenterology & hepatology, 2001-12, Vol.13 (12), p.1507-1508

2001

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis

Gastroenterology (New York, N.Y. 1943), 2003-10, Vol.125 (4), p.1042-1052

2003

Link zum Volltext

Verfügbarkeit prüfen

Graft versus Host Disease after Orthotopic Liver Transplantation Documented by Analysis of Short Tandem Repeat Polymorphisms

Digestion, 2006-01, Vol.74 (3-4), p.169-173

2006

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of GBV-C HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis

The American journal of gastroenterology, 1999-11, Vol.94 (11), p.3336-3340

1999

Link zum Volltext

Verfügbarkeit prüfen

Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation

European journal of gastroenterology & hepatology, 2000-08, Vol.12 (8), p.941-948

2000

Link zum Volltext

Verfügbarkeit prüfen

Hereditary Hemochromatosis as a Risk Factor for Joint Replacement Surgery

The American journal of medicine, 2010-07, Vol.123 (7), p.659-662

2010

Link zum Volltext

Verfügbarkeit prüfen

Hepatocellular carcinoma - survival and clinical characteristics in relation to various histologic molecular markers in Western patients

Liver international, 2005-02, Vol.25 (1), p.62-69

2005

Link zum Volltext

Verfügbarkeit prüfen

The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis

Digestive diseases and sciences, 2006-02, Vol.51 (2), p.338-345

2006

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of hepatitis G-virus infection in alcohol abusing patients with and without liver cirrhosis

Wiener Klinische Wochenschrift, 1998-10, Vol.110 (19), p.686

1998

Link zum Volltext

Verfügbarkeit prüfen

Mutations of the HFE gene in patients with hepatocellular carcinoma

The American journal of gastroenterology, 2003-02, Vol.98 (2), p.442-447

2003

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: HCC: prognostic factors for sorafenib therapy

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.949-959

2011

Link zum Volltext

Verfügbarkeit prüfen

SAT-269 - Outcome after the use of SX-ELLA Danis bleeding stents for refractory variceal bleeding- a Vienna Multicenter Experience

Journal of hepatology, 2018-04, Vol.68, p.S729-S730

2018

Link zum Volltext

Verfügbarkeit prüfen

Outcome after the use of SX-ELLA Danis bleeding stents for refractory variceal bleeding- a Vienna Multicenter Experience

Journal of hepatology, 2018-04, Vol.68, p.S729-S730

2018

Link zum Volltext

Verfügbarkeit prüfen

Lack of evidence for involvement of fetal microchimerism in pathogenesis of primary biliary cirrhosis

Digestive diseases and sciences, 2002-09, Vol.47 (9), p.1909-1914

2002

Link zum Volltext

Verfügbarkeit prüfen

SAT-270 - The beneficial effects of non-selective betabockers in secondary prophylaxis are most pronounced in patients without refractory ascites

Journal of hepatology, 2018-04, Vol.68, p.S730-S731

2018

Link zum Volltext

Verfügbarkeit prüfen

The beneficial effects of non-selective betabockers in secondary prophylaxis are most pronounced in patients without refractory ascites

Journal of hepatology, 2018-04, Vol.68, p.S730-S731

2018

Link zum Volltext

Verfügbarkeit prüfen

Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinoma

Journal of immunotherapy (1997), 2002-11, Vol.25 (6), p.489

2002

Link zum Volltext

Verfügbarkeit prüfen

Hepatic pathology in C282Y/H63D compound heterozygotes

Journal of hepatology, 2000, Vol.32, p.133-133

2000

Link zum Volltext

Verfügbarkeit prüfen

Failure to detect fetal microchimerism in patients with primary biliary cirrhosis

Journal of hepatology, 2000, Vol.32, p.130-130

2000

Link zum Volltext

Verfügbarkeit prüfen

Artificial blood chimerism and graft-versus-host disease after liver transplantation

International Congress series, 2006-04, Vol.1288, p.840-842

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

Hepatocellular carcinoma in Central Europe: prognostic features and survival

Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori

Pilot study: rapamycin in advanced hepatocellular carcinoma

Elevated serum levels of sFas in acute viral hepatitis

Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis

Graft versus Host Disease after Orthotopic Liver Transplantation Documented by Analysis of Short Tandem Repeat Polymorphisms

Prevalence of GBV-C HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis

Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation

Hereditary Hemochromatosis as a Risk Factor for Joint Replacement Surgery

Hepatocellular carcinoma - survival and clinical characteristics in relation to various histologic molecular markers in Western patients

The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis

Prevalence of hepatitis G-virus infection in alcohol abusing patients with and without liver cirrhosis

Mutations of the HFE gene in patients with hepatocellular carcinoma

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: HCC: prognostic factors for sorafenib therapy

SAT-269 - Outcome after the use of SX-ELLA Danis bleeding stents for refractory variceal bleeding- a Vienna Multicenter Experience

Outcome after the use of SX-ELLA Danis bleeding stents for refractory variceal bleeding- a Vienna Multicenter Experience

Lack of evidence for involvement of fetal microchimerism in pathogenesis of primary biliary cirrhosis

SAT-270 - The beneficial effects of non-selective betabockers in secondary prophylaxis are most pronounced in patients without refractory ascites

The beneficial effects of non-selective betabockers in secondary prophylaxis are most pronounced in patients without refractory ascites

Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinoma

Hepatic pathology in C282Y/H63D compound heterozygotes

Failure to detect fetal microchimerism in patients with primary biliary cirrhosis

Artificial blood chimerism and graft-versus-host disease after liver transplantation

Suchergebnisse filtern